Grifols SA
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Drug Manufacturers - General
業務概覽 Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses onproducts derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
公司地址 Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
電話號碼 +34 935710500
傳真號碼 +34 938008000
公司網頁 https://www.grifols.com
員工數量 25247
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Ignacio Ramal Subira Chief Internal Audit and Enterprise Risk Manager -- 17/04/2026
Mr. Jose Ignacio Abia Buenache Director and Chief Executive Officer -- 17/04/2026
Mr. Lluis Pons Gomez Senior Vice President, Strategy -- 17/04/2026
Ms. Montserrat Ribas Lloveras Chief Communications and Reputation Officer -- 17/04/2026
Mr. Jordi Balsells Valls President, Plasma Procurement -- 17/04/2026
Ms. Laura de la Cruz Galan Director and Secretary -- 17/04/2026
Mr. Camille Alpi Chief Human Resources and Talent Officer -- 17/04/2026
Ms. Nuria Martin Barnes Vice Secretary -- 17/04/2026
Mr. David Ian Bell Chief Corporate Development Officer -- 17/04/2026
Mr. Oscar Calsamiglia Mendlewicz General Counsel -- 17/04/2026
Mr. Rahul Srinivasan Chief Financial Officer -- 17/04/2026
Mr. Daniel Fleta Coit Chief Industrial Services Officer -- 17/04/2026
Dr. Antonio Martinez Martinez President, Diagnostic -- 17/04/2026
Dr. Roland Wandeler, PhD President, Biopharma Business Unit -- 17/04/2026
Mr. Jaime Gonzalez Peralta Chief Digital Information Officer -- 17/04/2026
Mr. Enrique de la Torre Chief Compliance Officer -- 17/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Jose Ignacio Abia Buenache Director and Chief Executive Officer 17/04/2026
Ms. Susana Gonzalez Rodriguez Independent Director 17/04/2026
Mr. Paul S. Herendeen Director 17/04/2026
Ms. Montserrat Munoz Abellana Lead Independent Director 17/04/2026
Ms. Anne-Catherine Berner Chairman of the Board 17/04/2026
Ms. Laura de la Cruz Galan Director and Secretary 17/04/2026
Mr. Tomas Daga Gelabert Director 17/04/2026
Mr. Raimon Grifols Roura Vice Chairman of the Board 17/04/2026
Mr. Inigo Sanchez-Asiain Mardones Independent Director 17/04/2026
Mr. Víctor Grifols Deu Director 17/04/2026
Mr. Pascal Ravery Independent Director 17/04/2026
Mr. Albert Grifols Coma-Cros Director 17/04/2026
Ms. Enriqueta Felip Font Independent Director 17/04/2026
 
所屬ETF (更新日期: 02/05/2026 04:28)
代號 名稱 佔比% ▼ 持有日期
IBBiShares Biotechnology ETF0.14%29/04/2026
BINVBrandes International ETF0.13%29/04/2026
KOMPStt Strt®SPDR®S&PKenshoNwEcosComposETF0.05%29/04/2026
SPDWState Street® SPDR® Ptf Dev Wld exUS ETF0.04%29/04/2026
BSMCBrandes U.S. Small-Mid Cap Value ETF0.04%29/04/2026
CGICCapital Group International Cor Eq ETF0.02%31/03/2026
APIEActivePassive International Equity ETF0.01%29/04/2026
IBBQInvesco Nasdaq Biotechnology ETF0.001%29/04/2026
BIBProShares Ultra Nasdaq Biotechnology0.001%29/04/2026
AADRAdvisorShares Dorsey Wright ADR ETF<0.000001%03/12/2025
AQECAQE Core ETF<0.000001%28/11/2025
AVTMAvantis Total Equity Markets ETF<0.000001%14/03/2026
ENDWCambria Endowment Style ETF<0.000001%26/02/2026
ONEQFidelity Nasdaq Composite ETF<0.000001%19/12/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.